Clinical Genitourinary Cancer is an Elsevier journal for clinical and translational research in prostate, kidney, bladder and other genitourinary cancers. Urologic oncologists and medical oncologists treating these tumours read it.
Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles on clinical and translational research in genitourinary cancers, devoted to detection, diagnosis, prevention and treatment of genitourinary malignancies with emphasis on recent scientific developments. Its stated areas of interest include clinical research and mechanistic approaches, drug sensitivity and resistance, gene and antisense therapy, pathology, markers and prognostic indicators, chemoprevention strategies, multimodality therapy and integration of approaches. The access model is not stated in the pages consulted and is therefore not recorded here. NLM records the title from 2005 as the successor to Clinical Prostate Cancer, with the note 'Prostate, kidney, & bladder', first published in Dallas by the Cancer Information Group and from 2009 by Elsevier, quarterly, with print issues ceasing in January 2009; it is indexed in MEDLINE and PubMed.
Shares Penile cancer, Testicular germ cell tumours, PubMed & Europe PMC, Renal cell carcinoma.
Shares Testicular germ cell tumours, PubMed & Europe PMC, Renal cell carcinoma, Bladder & urothelial cancer.
Shares PubMed & Europe PMC, Prostate cancer.
Shares PubMed & Europe PMC, Prostate cancer.